EXO Biologics
Beatrice De Vos serves as the Chief Medical Officer at EXO Biologics since January 2021 and has held a position as a clinical research expert with the World Health Organization since 2019. With extensive experience in the pharmaceutical industry, Beatrice De Vos has contributed to vaccine development as an advisor at the TuBerculosis Vaccine Initiative since 2016 and established Bejamad sprl/bvba in 2007, providing strategic advice in clinical, regulatory, and medical affairs. Previous roles include Chief Medical Officer at NOVADIP Biosciences S.A. and PDC*line Pharma, and Chairman of the Board of Directors at BioTech Tools. Educational credentials include a medical degree from KUL, a PhD in medical sciences from UIAntwerpen, and specialization in pharmaceutical sciences.
This person is not in any teams
EXO Biologics
EXO Biologics is a Belgian clinical-stage biotechnology company focusing on researching and developing novel sub-cellular therapeutic candidates based on exosomes. Exo Biologics mission is to provide affordable and accessible exosomes therapies to patients with unmet medical needs. Exo Biologics has strong partnerships and influential networks for collaborating and researching new medical treatments, including research centers, public universities, and private partners.